Medicinal Cannabis is cannabis that is grown and sold pursuant to the Medicinal Cannabis Industry Act, 2019 that includes the seeds, immature plants as well as all parts of the plant, along with resin extracted from any part of the plant, every compound, manufacture, salt, derivative, mixture or preparation from cannabis; or cannabis concentrate; that is cultivated, processed, manufactured, distributed or sold under a licence from the BMCLA. As a medicine, it is prescribed and recommended by physicians to provide a therapeutic effect.

A patient may designate a person as a caregiver and that person has the responsibility for the immediate care and safety of the patient; to assist the patient with obtaining or using medicinal cannabis or to act in the best interest of the patient. A receiver appointed for a person by the Court, under the Mental Health Act Cap. 45, or where relevant a guardian in accordance with the provisions of the Mental Health Act, shall be deemed to be the caregiver of a person to who the Act applies.

A parent or legal guardian of a patient who is a minor shall be deemed to be the caregiver for that minor, unless that parent or legal guardian designates another person, or a person is designated by an order of the Court.

Cannabinoids are chemicals which interact with the endocannabinoid system in mammals. These can be found in the Cannabis plant (phytocannabinoids), endogenously derived (endocannabinoids) or synthesised chemically. Research has found that the cannabis plant produces approximately 120 cannabinoids and about 300 non-cannabinoid chemicals. The two main clinically relevant cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The most commonly known of the two is delta-9-tetrahydrocannabinol (THC), which is the chemical that is primarily responsible for the psychoactive effects of cannabis.

Cannabidiol (CBD) is one of the bioactive compounds and naturally occurring cannabinoids in the cannabis plant. It is one of the most medically relevant chemical compounds found in the cannabis plant, but it’s different from THC because of its opposing antagonistic effect compared to THC. It is also not as psychoactive as THC and is noted more for its medicinal effects.

A patient who needs to change his or her caregiver should notify his or her medical practitioner of the change, and give that medical practitioner such information as the medical practitioner may require in respect of the new caregiver.

• develops policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner;

• regulates the handling of medicinal cannabis;

• issues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Barbados Medicinal Industry Act;

• develops enforcement procedures in relation to the inspection of premises that are operated by a person in order to ensure compliance with the provisions of the Barbados Medicinal Industry Act or any regulations made pursuant to this Act;

• where required, assists with the provision of analytical services;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database to:

  • Collect, collate and include information relating to persons who handle medicinal cannabis or cannabis in accordance with this Act; and

  • Provide for the electronic tracking of the handling of medicinal cannabis or cannabis in accordance with the Barbados Medicinal Industry Act;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, requests from the Minister of Health such information as may assist the BMCLA with its functions;

• provides for the distribution of educational materials and the conduct of training programmes in relation to the development and use of medicinal cannabis and the medicinal cannabis industry;

• ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Barbados Medicinal Industry Act;

• performs such other functions assigned to it under the Barbados Medicinal Industry Act or any other enactment; and

• enters into any arrangement, which, in the opinion of the BMCLA, is necessary to ensure the proper performance of its functions.